Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
CCCC
#3431
C4 Therapeutics, Inc.
2.8
5
USD
+2.52%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+2.52%
Aylık Değişim
+2.89%
6 aylık değişim
+34.43%
Yıllık Değişim
+137.50%
Önceki Kapanış
2.7
8
Open
2.7
8
Bid
Ask
Low
2.7
6
High
2.8
6
Hacim
105
Piyasalar
ABD Borsası
Sağlık Hizmetleri
CCCC
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
43.12 M
48.74 M
49.05 M
68.6 M
70.99 M
97.58 M
—
Valuation ratios
Enterprise value
1.26 B
1.5 B
294.67 M
320.69 M
200.06 M
111.77 M
354.05 M
Price to earnings ratio
—
—
-2.44
-2.44
-2.37
-1.5
-4.81
Price to sales ratio
—
—
10.03
16.38
7.02
4.4
15.38
Price to cash flow ratio
—
—
-2.94
-3.03
-3.83
-1.6
-5.82
Price to book ratio
—
—
1.08
1.32
1.16
0.62
1.07
Enterprise value to EBITDA ratio
—
—
-2.91
-2.76
-1.62
-0.96
-2.9
Profitability ratios
Return on assets %
-0.17
-0.17
-0.3
-0.35
-0.3
-0.29
-0.35
Return on equity %
-0.24
-0.22
-0.44
-0.54
-0.49
-0.41
-0.57
Return on invested capital %
-460.27
-166.92
-258.91
-353.17
-358.18
-365.14
-419.29
Gross margin %
—
—
100
105.06
100
100
400
Operating margin %
—
—
-416.56
-703.74
-336.15
-320.53
-1 360.45
EBITDA margin %
—
—
-406.58
-717.92
-347.17
-323.87
-1 344.95
Net margin %
—
—
-412.19
-670.65
-295.96
-292.08
-1 238.66
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
8.69
6.36
6.46
6.34
5.71
7.81
24.32
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
0.07
0.05
0.1
0.1
0.12
Solvency ratios
Debt to assets ratio
0.03
0.02
0.03
0
—
—
—
Debt to equity ratio
0.04
0.03
0.04
0
—
—
—
Long term debt to total assets ratio
0.03
0.02
0.02
0
—
—
—
Long term debt to total equity ratio
0.04
0.03
0.03
0
—
—
—
Per share metrics
Operating cash flow per share
—
—
-2.17
-2.15
-0.94
-1.19
-1.34
EBIT per share
—
—
-2.65
-2.82
-1.72
-1.39
-1.57
EBITDA per share
—
—
-2.59
-2.86
-1.78
-1.4
-1.55
Total debt per share
—
—
0.23
0
—
—
—
Cash per share
—
—
6.9
5.67
3.85
3.58
12.79
Net current asset value per share
—
—
5.89
5.46
3.72
3.11
12.41
Tangible book value per share
—
—
5.92
4.96
3.11
3.1
10.43
Working capital per share
—
—
4.97
4.6
3.06
2.72
10.32
Book value per share
—
—
5.92
4.96
3.11
3.1
10.43
Haberler
C4 Therapeutics tüzüğünü güncelledi, federal mahkemeler özel forum oldu
What's Going On With C4 Therapeutics Stock Thursday? - C4 Therapeutics (NASDAQ:CCCC)
C4 Therapeutics hisseleri genişleyen Roche ortaklığıyla yükseldi
C4 Therapeutics, Roche kanser tedavisi için ortaklık kurdu
Is C4 Therapeutics (CCCC) Stock Outpacing Its Medical Peers This Year?
C4 Therapeutics, cemsidomide için elranatamab ile deneme başlattı
Are You Looking for a Top Momentum Pick? Why C4 Therapeutics, Inc. (CCCC) is a Great Choice
Is BrightSpring Health Services, Inc. (BTSG) Stock Outpacing Its Medical Peers This Year?
Barclays, C4 Therapeutics’in hisse hedefini yükseltti
Barclays raises C4 Therapeutics stock price target on trial progress
TD Cowen, C4 Therapeutics için Al tavsiyesini yineledi
TD Cowen reiterates Buy rating on C4 Therapeutics stock